Hospitals and generic drugmakers have join big pharma lobbyists who have said such trade barriers will cause shortages of ...

This recent report from The Boyd Company provides a look at operating costs for advanced manufacturing and corporate offices across 60 locations.

This follows a global transaction between GlaxoSmithKline plc, UK (GSK) and Novartis AG, Switzerland (Novartis ... towards renovation of its corporate office into a modern workplace.

European stocks closed lower on Friday with the mood turning cautious as investors assessed the latest batch of economic data from ...

The FTSE 100 finished up 103.99 at 8727.28 - a new record closing high. It also hit a new intraday record of 8,767.50 earlier ...

The European stock markets closed mostly higher in Wednesday trading as The Stoxx Europe 600 gained 0.36%, Germany's DAX 40 was up 0.22%, the FTSE 100 in London rose 0.61%, France's CAC 40 was off ...

It was approved in the US with a similar label last year after priority review, becoming the first oral alternative to GSK's injectable ... also been filed with the Swiss Agency for Therapeutic ...

It included two of the March portfolio’s top three holdings: European drugmakers GSK and Sanofi ... in Shanghai in 2021—its first investment office outside of San Francisco.

Switzerland: The Swiss National Science Foundation (grants no 33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, ...

holds part of a patent for the assessment of dyskinesia (German patent office, 102015220741.2) and received speaker's honoraria from GlaxoSmithKline, Abbvie, UCB, Licher MT and Rölke Pharma, unrelated ...

NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Now, GSK is ready to play catch up after nabbing its own FDA approval. The FDA approved the British drugmaker's Penmenvy vaccine to protect people ages 10 to 25 against meningococcal serogroups A ...